---
$id: https://graph.org.ai/products/commodity/51321503
$type: Product
source: UNSPSC
code: "51321503"
title: "Alirocumab"
class: "51321500"
classTitle: "Antihyperlipidemic and hypocholesterolemic benzene derivatives"
family: "51320000"
familyTitle: "Antihyperlipidemic and hypocholesterolemic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Alirocumab

**UNSPSC Code**: 51321503
**Class**: [Antihyperlipidemic and hypocholesterolemic benzene derivatives](Antihyperlipidemic and hypocholesterolemic benzene derivatives.mdx)
**Family**: [Antihyperlipidemic and hypocholesterolemic agents](../Antihyperlipidemic and hypocholesterolemic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

Alirocumab is a PCSK9 inhibitor used as an adjunct to manage heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in patients who require additional lowering of LDL-cholesterol (LDL-C)

